A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug in Participants With Lung Cancer (NSCLC)

NCT02079636 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

142

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Non-small Cell Lung

Interventions

DRUG: Abemaciclib
DRUG: Pemetrexed
DRUG: Gemcitabine
DRUG: Ramucirumab
DRUG: LY3023414
DRUG: Pembrolizumab

Sponsor

Eli Lilly and Company

Collaborators

[object Object]